Comera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial Officer


WOBURN, Mass.(BUSINESS WIRE)Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bioinnovative biologic medicines to improve patient access, safety, and convenience, today announced the appointment of Michael Campbell as Executive Vice President and Chief Financial Officer. He had served as interim Chief Financial Officer since April 13, 2022 and will continue to oversee Comera’s finance operations, including accounting and reporting, corporate tax, treasury and investor relations. “We are excited that Michael will continue as our Chief Financial Officer after serving in an interim capacity since April. He brings extensive expertise and leadership in business finance across the medical device and medical diagnostics industries and will be a strong addition to our leadership team as we embark on our new chapter as a public company,” said Jeff Hackman, Chief Executive Officer and Chairman of Comera. “This is an exciting time for Comera with a number of partnerships underway, and we are wellpositioned to help maximize the true potential of lifechanging biologics by transforming them from intravenous to subcutaneous forms that patients can administer themselves.” Campbell has over 30 years of financial leadership experience across global public companies, spanning corporate finance, accounting and reporting, investor relations, corporate tax, international business
operations and merger and acquisitions. Prior to joining Comera as a consultant through Monomoy Advisors LLC, Campbell held several senior finance leadership roles at Ortho Clinical Diagnostics, including serving in the Office of the CFO and as Vice President, Corporate Controller and Head of Global Tax. Campbell held various senior leadership positions within Boston Scientific Corporation, including Vice President of Investor Relations and regional CFO as Vice President of Finance, Asia Pacific and Emerging Markets based in Singapore. While at Boston Scientific, Campbell was actively involved in over 20 acquisitions and more than 100 strategic alliances and oversaw business segments covering more than 40 countries. Early in Campbell’s career, he was a Financial and Information Systems Assurance Manager at Ernst & Young. Campbell received a B.S. degree in Accountancy from Bentley University and is a Certified Public Account.
“I am excited to leverage my experience to help drive the company’s business and financial growth as we execute on our strategic vision,” said Campbell. “I am thrilled to join a missiondriven company that is building a compassionate new era in medicine and I look forward to working with the Comera leadership team as we work to improve patient lives and deliver value for our shareholders.”